Peter Dumas
Gastroenterology · Venice, FLNPI 1043245665
Payments from drug & device makers
Across 415 payments — averaging $19.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$811
- Johnson & Johnson$698
- Takeda Pharmaceuticals U.S.A., Inc.$607
- Bristol Myers Squibb$340
- Pfizer$302
- plus $2K from 26 others
What the payments were for
- Consulting fees$190%
- Food & beverage$8,02798%
- Education$1161%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 185 | $3,220 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 45 | $811 |
| Johnson & Johnson | 35 | $698 |
| Takeda Pharmaceuticals U.S.A., Inc. | 34 | $607 |
| Bristol Myers Squibb | 18 | $340 |
| Pfizer | 12 | $302 |
| Ironwood Pharmaceuticals, Inc | 10 | $208 |
| Sanofi | 6 | $192 |
| Vivus LLC | 10 | $191 |
| Medtronic(2 entities) | 2 | $184 |
| Braintree Laboratories, Inc. | 9 | $156 |
| Axonics, Inc. | 3 | $137 |
| Intercept Pharmaceuticals, Inc. | 2 | $129 |
| UCB, Inc. | 7 | $113 |
| Regeneron | 1 | $104 |
| Shionogi Inc | 5 | $102 |
| Ferring Pharmaceuticals Inc. | 4 | $76 |
| E.r. Squibb & Sons, L.L.C. | 2 | $75 |
| Fujifilm Healthcare Americas Corporation | 1 | $72 |
| Redhill Biopharma Inc. | 5 | $68 |
| Regeneron Healthcare Solutions, Inc. | 3 | $66 |
| Amgen | 2 | $49 |
| QOL Medical, LLC | 3 | $45 |
| Merck | 2 | $41 |
| Ardelyx, Inc. | 2 | $36 |
| Mauna Kea Technologies, Inc. | 1 | $27 |
| Pharmacosmos Therapeutics Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $23 |
| Covidien LP | 1 | $20 |
| Boehringer Ingelheim | 1 | $16 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Gilead | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,162 in reported general payments places this provider in the 70th percentile of 1,388 gastroenterology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 161 | $2,345 |
| Omeprazole | 128 | $1,728 |
| Sucralfate | 18 | $410 |
| Famotidine | 24 | $185 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Venice
- Howard SchwartzTavernier$38.8M
- Guy NeffSarasota$17.6M
- Syed LateefClermont$6.4M
- Jeffrey SchneiderCoral Springs$6M
- Zaid RanaMiami$5.4M
- David NelsonGainesville$5.2M
- Alan WeintraubTampa$4.7M
- Curtis FreedlandNew Port Richey$4.5M
- Paul HellsternCrystal River$4.5M
- Henry LevineOrlando$3.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.